| Course Name |
Manufacturing of Cell & Gene Therapies and Vaccines |
| Course Provider |
University College Dublin |
| Course Code |
T373 |
| Course Type |
Postgraduate |
| Qualifications |
| Award Name | NFQ Classification | Awarding Body | NFQ Level |
| Professional Certificate |
|
National University of Ireland |
None |
|
| Apply To |
Course provider |
| Attendance Options |
Part time, Online or Distance |
| Location (Districts) |
Belfield |
| Qualification Letters |
ProfCert |
| Enrolment and Start Dates Comment |
NEXT INTAKE: 2022/2023 September |
| Application Date |
UCD's graduate taught courses can be applied for online
The following entry routes are available:
PC Manufacturing of Cell & Gene Therapies and Vaccines PT (T373)
Duration 6 Months
Attend Part Time
Deadline Rolling*
* Courses will remain open until such time as all places have been filled, therefore early application is advised |
| Application Weblink |
Web Page - Click Here |
| Duration |
6 months part-time
The modules will be delivered in a hybrid format with the option to attend in-person lectures on the UCD campus or to study remotely. Lectures will take place on Friday evenings from 2 - 6 pm over the Autumn trimester (12 weeks, Sep - Dec). |
| Course Fee |
ProfCert Manufacturing of Cell & Gene Therapies and Vaccines (T373) Part Time
EU fee per year - € 3500
nonEU fee per year - € 7000
***Fees are subject to change |
| Link to Course Fee |
Web Page - Click Here |
| Entry Requirements |
An honours undergraduate degree (NFQ level 8) with a minimum second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account.
Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent. |
| Comment |
Expand+Who should apply
Part Time option suitable for:
Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. No
Related Programmes
MEngSc Biopharmaceutical Engineering PT
MEngSc Biopharmaceu...
Hide-Who should apply
Part Time option suitable for:
Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. No
Related Programmes
MEngSc Biopharmaceutical Engineering PT
MEngSc Biopharmaceutical Engineering FT
MEngSc Chemical Engineering FT
Teaching will take place in parallel in-person on the UCD campus and online. Students will have an opportunity to tour the NIBRT facility which is a purpose-built, multi-functional building replicating the most modern industrial bioprocessing facility. The total building area is approximately 6,500 m² over two floors.
|
| Course Content |
Expand+Ireland has a strong reputation as a Centre of Excellence for biopharmaceutical production. All of the top 10 global pharmaceutical companies have a presence in Ireland and the sector as a whole employs over 30,000 people and contributes €54 billi...
Hide-Ireland has a strong reputation as a Centre of Excellence for biopharmaceutical production. All of the top 10 global pharmaceutical companies have a presence in Ireland and the sector as a whole employs over 30,000 people and contributes €54 billion in exports. There has been significant, sustained investment in recent years and this is set to continue due to the benefits which companies see in our highly skilled workforce, proven track record and the supportive ecosystem.
Vaccines and cell and gene therapies (CGTs) are an emerging and rapidly growing area of interest and Ireland is poised to continue expansion of manufacturing into this exciting area. This programme will provide students with an appreciation of the science and challenges associated with CGT and vaccine manufacture as part of their continuing professional development (CPD) and support them to pursue a successful career in the field.
The programme and its academic faculty are closely linked with the National Institute for Bioprocess Research and Training (NIBRT) which is a global centre of excellence for training and research in biomanufacturing. Content will be delivered by a blend of industrial leaders and academic experts using a hybrid approach ensuring a high quality, relevant curriculum accessible both in person and remotely.
|
| Subjects Taught |
Modules offered:
Cell Therapy Technologies and Processing
Gene Therapy and Vaccine Technologies and Processing
GMP Manufacturing of Advanced Therapeutics |
| Number of Credits |
15 |
| Careers or Further Progression |
Expand+The Professional Certificate is suitable for Science and Engineering graduates currently working in the biopharmaceutical industry or looking to move into the sector, who wish to expand their skill set to take advantage of the growth in the vaccine, ...
Hide-The Professional Certificate is suitable for Science and Engineering graduates currently working in the biopharmaceutical industry or looking to move into the sector, who wish to expand their skill set to take advantage of the growth in the vaccine, and cell and gene therapies space. The number of companies active in this area is currently growing with Pfizer, Takeda, WuXi, MeiraGTx, VLE, Avectas, Onk and Orbsen Therapeutics leading the way.
Further Study
The credits gained can be used toward further postgraduate qualifications offered by UCD should participants wish to pursue a higher qualification e.g. Graduate Certificate (30 credits) / Graduate Diploma (60 credits)/ MEngSc in Biopharmaceutical Engineering (90 credits).
|
| Further Enquiries |
CONTACT NAME: Laura Egan-O'Brien
CONTACT NUMBER: +35317161916 |
| Course Web Page |
Web Page - Click Here |
| International Students |
Web Page - Click Here |